Adjuvant sorafenib reduced mortality and prolonged overall survival and post-recurrence survival in hepatocellular carcinoma patients after curative resection: A single-center experience-Reference-Cited by-同舟云学术

Adjuvant sorafenib reduced mortality and prolonged overall survival and post-recurrence survival in hepatocellular carcinoma patients after curative resection: A single-center experience

Published:2014 Issue:6 Volume:8 Page:333-338
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Zhang Wei¹,Zhao Gang¹,Wei Kai¹,Zhang Qingxiang¹,Ma Weiwei¹,Song Tianqiang¹,Wu Qiang¹,Zhang Ti¹,Kong Dalu¹,Li Qiang¹

Affiliation:

1. Department of Hepatobiliary Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical ResearchCenter for Cancer and Key Laboratory of Cancer Prevention and Therapy

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health (social science)

Reference30 articles.

1. 1. Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003-2005: A population-based study. Int J Cancer. 2014. doi:10.1002/ijc.29227

2. 2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69-90.

3. 3. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014; 64:9-29.

4. 4. Tang ZY. Hepatocellular carcinoma surgery--review of the past and prospects for the 21st century. J Surg Oncol. 2005; 91:95-96.

5. 5. Fan ST, Mau Lo C, Poon RT, Yeung C, Leung Liu C, Yuen WK, Ming Lam C, Ng KK, Ching Chan S. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: A 20-year experience. Ann Surg. 2011; 253:745-758.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noninvasive identification of SOX9 status using radiomics signatures may help construct personalized treatment strategy in hepatocellular carcinoma;Abdominal Radiology;2024-03-06

2. Survival benefit and impact of adjuvant therapies following FOLFOX-HAIC-based conversion therapy with unresectable hepatocellular carcinoma: a retrospective cohort study;Journal of Cancer Research and Clinical Oncology;2023-08-17

3. Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma;Journal of Cancer Research and Clinical Oncology;2023-06-07

4. Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy;Chinese Medical Journal;2023-05-29

5. Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?;Cancers;2023-05-27